Upgrade to SI Premium - Free Trial

Kymera Therapeutics (KYMR) PT Raised to $170 at Guggenheim

August 31, 2026 7:09 AM
(Updated - August 31, 2026 7:11 AM EDT)

Guggenheim analyst Brad Canino raised the price target on Kymera Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change